Preventing progression from gestational diabetes mellitus to diabetes: A thought-filled review
- PMID: 28544499
- DOI: 10.1002/dmrr.2909
Preventing progression from gestational diabetes mellitus to diabetes: A thought-filled review
Abstract
Women with a history of gestational diabetes are at high risk for developing type 2 diabetes mellitus. In studies with long periods of follow-up, diabetes incidence of up to 70% has been reported. The appropriate follow-up of women following a pregnancy complicated by gestational diabetes has not been studied. Published guidelines recommend that obstetrician/gynaecologists, who are often the de facto primary care physicians for these otherwise healthy young women, incorporate glucose monitoring in the post-partum period into their annual examinations. In reality, reported rates of screening have been low. There is also no clear evidence for any beneficial interventions to prevent diabetes in patients with prior history of gestational diabetes. Lifestyle intervention programmes for diabetes prevention among these patients yielded disappointing results. Metformin, pioglitazone, liraglutide, and bariatric surgery are possible options but based on inadequate data. There remains a need for randomized, placebo-controlled studies to evaluate various pharmacologic treatments, with and without lifestyle interventions, to prevent type 2 diabetes mellitus in women with a history of gestational diabetes.
Keywords: diabetes prevention; gestational diabetes; liraglutide; metformin; pioglitazone.
Copyright © 2017 John Wiley & Sons, Ltd.
Similar articles
-
Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9. doi: 10.1210/jc.2008-0772. Epub 2008 Sep 30. J Clin Endocrinol Metab. 2008. PMID: 18826999 Free PMC article. Clinical Trial.
-
The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up.J Clin Endocrinol Metab. 2015 Apr;100(4):1646-53. doi: 10.1210/jc.2014-3761. Epub 2015 Feb 23. J Clin Endocrinol Metab. 2015. PMID: 25706240 Free PMC article. Clinical Trial.
-
Genetic risk of progression to type 2 diabetes and response to intensive lifestyle or metformin in prediabetic women with and without a history of gestational diabetes mellitus.Diabetes Care. 2014 Apr;37(4):909-11. doi: 10.2337/dc13-0700. Epub 2013 Nov 22. Diabetes Care. 2014. PMID: 24271189 Free PMC article.
-
Metformin therapy and diabetes in pregnancy.Med J Aust. 2004 May 3;180(9):462-4. Med J Aust. 2004. PMID: 15115425 Review.
-
Metformin in Prevention of Type 2 Diabetes.J Assoc Physicians India. 2018 Mar;66(3):60-3. J Assoc Physicians India. 2018. PMID: 30341871 Review.
Cited by
-
Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control.BMJ Open Diabetes Res Care. 2021 Nov;9(2):e002382. doi: 10.1136/bmjdrc-2021-002382. BMJ Open Diabetes Res Care. 2021. PMID: 34750153 Free PMC article.
-
Effect of gestational diabetes and hypertensive disorders of pregnancy on postpartum cardiometabolic risk.Endocr Connect. 2018 Mar;7(3):433-442. doi: 10.1530/EC-17-0359. Epub 2018 Feb 14. Endocr Connect. 2018. PMID: 29444890 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical